Yigal Nochomovitz
Stock Analyst at Citigroup
(3.35)
# 2,631
Out of 5,182 analysts
340
Total ratings
47.25%
Success rate
2.94%
Average return
Main Sectors:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LGND Ligand Pharmaceuticals | Maintains: Buy | $276 → $282 | $231.82 | +21.65% | 3 | Apr 15, 2026 | |
| TVTX Travere Therapeutics | Maintains: Buy | $48 → $53 | $40.77 | +30.00% | 1 | Apr 14, 2026 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $204 → $242 | $133.25 | +81.61% | 4 | Apr 7, 2026 | |
| APLS Apellis Pharmaceuticals | Downgrades: Neutral | $44 → $41 | $40.90 | +0.24% | 20 | Apr 1, 2026 | |
| BMEA Biomea Fusion | Maintains: Buy | $6 → $7 | $2.21 | +216.74% | 12 | Mar 27, 2026 | |
| LENZ LENZ Therapeutics | Maintains: Buy | $52 → $26 | $10.18 | +155.40% | 5 | Mar 26, 2026 | |
| SRPT Sarepta Therapeutics | Maintains: Sell | $9 → $13 | $21.55 | -39.68% | 3 | Mar 26, 2026 | |
| ARVN Arvinas | Maintains: Buy | $18 → $21 | $11.00 | +90.91% | 13 | Mar 19, 2026 | |
| CADL Candel Therapeutics | Maintains: Buy | $22 → $26 | $6.37 | +308.16% | 4 | Mar 18, 2026 | |
| ZBIO Zenas BioPharma | Maintains: Buy | $43 → $41 | $21.83 | +87.86% | 3 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $62 | $16.82 | +268.61% | 4 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $7 | $7.53 | -7.04% | 6 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $8.03 | +12.08% | 2 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.1 → $2.3 | $1.87 | +22.99% | 13 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $35 | $14.93 | +134.43% | 2 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $33 | $29.64 | +11.34% | 5 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $45 | $24.25 | +85.57% | 10 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $8 | $8.85 | -9.60% | 10 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $24.94 | +68.40% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $57 | $24.23 | +135.25% | 10 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $17 | $10.75 | +58.14% | 8 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $65 | $33.91 | +91.68% | 4 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $336 → $371 | $274.21 | +35.30% | 11 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $14 | $6.45 | +117.05% | 17 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $36 | $22.17 | +62.38% | 2 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $77 | $57.99 | +32.78% | 22 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $399 → $405 | $323.87 | +25.05% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $8.63 | +62.22% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $8 | $2.20 | +263.64% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $40 | $25.15 | +59.05% | 6 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $69 | $24.19 | +185.24% | 9 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $22 | $27.80 | -20.86% | 17 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.18 | +312.84% | 2 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $55 | $32.43 | +69.60% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $3.46 | +304.62% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $2.91 | -58.76% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $1.99 | +0.50% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $1.80 | +344.44% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $2.27 | -55.95% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $5.27 | +564.14% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $24.81 | +436.07% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $4.42 | +261.99% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.39 | +619.42% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.66 | +622.89% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $7.47 | - | 14 | Sep 28, 2021 |
Ligand Pharmaceuticals
Apr 15, 2026
Maintains: Buy
Price Target: $276 → $282
Current: $231.82
Upside: +21.65%
Travere Therapeutics
Apr 14, 2026
Maintains: Buy
Price Target: $48 → $53
Current: $40.77
Upside: +30.00%
Neurocrine Biosciences
Apr 7, 2026
Maintains: Buy
Price Target: $204 → $242
Current: $133.25
Upside: +81.61%
Apellis Pharmaceuticals
Apr 1, 2026
Downgrades: Neutral
Price Target: $44 → $41
Current: $40.90
Upside: +0.24%
Biomea Fusion
Mar 27, 2026
Maintains: Buy
Price Target: $6 → $7
Current: $2.21
Upside: +216.74%
LENZ Therapeutics
Mar 26, 2026
Maintains: Buy
Price Target: $52 → $26
Current: $10.18
Upside: +155.40%
Sarepta Therapeutics
Mar 26, 2026
Maintains: Sell
Price Target: $9 → $13
Current: $21.55
Upside: -39.68%
Arvinas
Mar 19, 2026
Maintains: Buy
Price Target: $18 → $21
Current: $11.00
Upside: +90.91%
Candel Therapeutics
Mar 18, 2026
Maintains: Buy
Price Target: $22 → $26
Current: $6.37
Upside: +308.16%
Zenas BioPharma
Mar 17, 2026
Maintains: Buy
Price Target: $43 → $41
Current: $21.83
Upside: +87.86%
Mar 17, 2026
Maintains: Buy
Price Target: $60 → $62
Current: $16.82
Upside: +268.61%
Mar 13, 2026
Maintains: Neutral
Price Target: $4 → $7
Current: $7.53
Upside: -7.04%
Mar 11, 2026
Maintains: Buy
Price Target: $7 → $9
Current: $8.03
Upside: +12.08%
Mar 10, 2026
Maintains: Buy
Price Target: $2.1 → $2.3
Current: $1.87
Upside: +22.99%
Mar 9, 2026
Maintains: Buy
Price Target: $31 → $35
Current: $14.93
Upside: +134.43%
Mar 6, 2026
Maintains: Buy
Price Target: $31 → $33
Current: $29.64
Upside: +11.34%
Mar 5, 2026
Maintains: Buy
Price Target: $44 → $45
Current: $24.25
Upside: +85.57%
Mar 4, 2026
Maintains: Neutral
Price Target: $7 → $8
Current: $8.85
Upside: -9.60%
Mar 3, 2026
Initiates: Buy
Price Target: $42
Current: $24.94
Upside: +68.40%
Mar 2, 2026
Maintains: Buy
Price Target: $51 → $57
Current: $24.23
Upside: +135.25%
Feb 24, 2026
Maintains: Buy
Price Target: $16 → $17
Current: $10.75
Upside: +58.14%
Feb 19, 2026
Maintains: Buy
Price Target: $64 → $65
Current: $33.91
Upside: +91.68%
Feb 18, 2026
Maintains: Buy
Price Target: $336 → $371
Current: $274.21
Upside: +35.30%
Jan 9, 2026
Maintains: Buy
Price Target: $11 → $14
Current: $6.45
Upside: +117.05%
Jan 6, 2026
Maintains: Buy
Price Target: $33 → $36
Current: $22.17
Upside: +62.38%
Nov 12, 2025
Maintains: Buy
Price Target: $87 → $77
Current: $57.99
Upside: +32.78%
Nov 10, 2025
Maintains: Buy
Price Target: $399 → $405
Current: $323.87
Upside: +25.05%
Nov 5, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $8.63
Upside: +62.22%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $2.20
Upside: +263.64%
Oct 20, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $25.15
Upside: +59.05%
Aug 11, 2025
Maintains: Buy
Price Target: $66 → $69
Current: $24.19
Upside: +185.24%
Aug 11, 2025
Maintains: Buy
Price Target: $19 → $22
Current: $27.80
Upside: -20.86%
Jul 9, 2025
Maintains: Buy
Price Target: $6 → $9
Current: $2.18
Upside: +312.84%
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $32.43
Upside: +69.60%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $3.46
Upside: +304.62%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $2.91
Upside: -58.76%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $1.99
Upside: +0.50%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $1.80
Upside: +344.44%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $2.27
Upside: -55.95%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $5.27
Upside: +564.14%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $24.81
Upside: +436.07%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $4.42
Upside: +261.99%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.39
Upside: +619.42%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.66
Upside: +622.89%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $7.47
Upside: -